Email this to a Friend

Close

Seminar Predicting combinatorial efficacy of Rituximab and Doxorubicin in non-hodgkin's lymphoma xenografts

Seminar -- Predicting combinatorial efficacy of Rituximab and Doxorubicin in non-hodgkin's lymphoma xenografts
Send a copy to myself